A major clinical problem in mentallly retarded children and adults is stereotyped behavior. Stereotyped behavior includes repetitive invariant topographic mannerisms, such as body rocking, head weaving, etc. Thioridazine (Mellaril ) is a phenothiazine antipsychotic drug that is the most frequently used psychtropic medication for control of behavior problems in retarded persons, including sterotypies. Despite its wide spread use, a number of questions remain concerning thioridazine's efficacy and the sequalae of its long term administration. This proposal will investigate how thioridazine affects the stereotypies in institutionalized mentally retarded persons. One study will investigate the effect of thioridazine withdrawal in clients who have been maintained on the drug and who are scheduled to be withdrawn. This experiment will also determine how environmental challenges affect withdrawal emergent symptons. A second study will examine the effects of both acute and chronic administration of thioridazine on stereotyped movements, including their rhythmical properties. A third study will investigate the interaction of pharmacotherapy with behavior management procedures. Data are presented to show that the actions of thioradazine may be due primarily to metabolites rather than the parent compound. A major strength of these studies are planned that will parallel the clinical studies. The animal studies will be done in hamsters, rather than rats, as preliminary data demonstrate that hamsters metabolize theoridazine in a way similar to that seen in humans. Thus, hamsters should provide a better model for pharmacodynamic studies with thioridazine. Chronic and acute drug effects, in combination with testing for effects of environmental challenges during withdrawal, will provide important animal data relevant to the interpretation of the clinical studies.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
3R01HD016834-03S1
Application #
3313985
Study Section
Reproductive Biology Study Section (REB)
Project Start
1982-07-01
Project End
1987-06-30
Budget Start
1984-07-01
Budget End
1987-06-30
Support Year
3
Fiscal Year
1985
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Mailman, R B; Schulz, D W; Kilts, C D et al. (1986) Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects. Psychopharmacol Bull 22:593-8
Schulz, D W; Staples, L; Mailman, R B (1985) SCH23390 causes persistent antidopaminergic effects in vivo: evidence for longterm occupation of receptors. Life Sci 36:1941-8
Lewis, M H; Baumeister, A A; McCorkle, D L et al. (1985) A computer-supported method for analyzing behavioral observations: studies with stereotypy. Psychopharmacology (Berl) 85:204-9
Schulz, D W; Stanford, E J; Wyrick, S W et al. (1985) Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor. J Neurochem 45:1601-11